Health Care

Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds ($9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment.

Anthem Inc. (ANTM) on Wednesday reported second-quarter earnings of $1.05 billion.

Chinese state media say a total of 15 people have been detained in a growing scandal over the faking of records by a rabies vaccine maker.

Drugmaker Pfizer Inc. plans to expand manufacturing in Michigan and add 450 jobs under an incentives deal approved Tuesday by the state's economic development arm.

Eli Lilly and Co. (LLY) on Tuesday reported a second-quarter loss of $259.9 million, after reporting a profit in the same period a year earlier.

IPO of unit expected in second half of year.

That hot lunch delivered to your door?

Private equity firm Apollo Global Management will spend about $5.6 billion to buy the rural hospital chain LifePoint and combine it with the health system operator RCCH HealthCare Partners.

Mondelez Global says it's voluntarily recalling some of its Ritz Cracker products over potential risk of salmonella.

U.S. regulators have approved a simpler, one-dose treatment to prevent relapses of malaria.

It's more than $1 billion over budget and five years behind schedule, but an elaborate new veterans hospital is finally opening in suburban Denver on Saturday with the promise of state-of-the-art medical care.

Here's what to do when it's hot outside but ridiculously cold in your workplace.

Federal safety investigators are looking into complaints that engines on some Ford Escape vehicles can overheat and suddenly stall while being driven.

A tornado slammed into an agricultural machinery plant in Iowa as some people were working on Thursday and police said a number of people were taken to a local hospital.

Health and Human Services Secretary Alex Azar said the Trump administration has taken several steps to lower the cost of prescription drugs.

The pair of drugmakers delayed plans to raise prices on U.S. products earlier this month.

Novartis AG, the big Swiss drug company, said Wednesday it will freeze U.S. drug prices for the rest of this year, a move that follows a similar one by Pfizer, according to Bloomberg.

Johnson & Johnson is reporting second-quarter earnings of $3.95 billion.